ÂÜŔňÂŇÂ×

Tanja Weber joined Epizyme in 2019 as Senior Vice President of Business Development and Alliance Management. Prior to joining Epizyme, Tanja was Vice President of Business Development at Agios Pharmaceuticals, where she built that company’s business development function and was responsible for in- and out-licensing activities and strategic collaboration initiatives. While at Agios, Tanja executed several early-stage in-licensing deals as well as a strategic development and commercialization collaboration on TIBSOVO® for Greater China. Before joining Agios, Tanja worked at Sanofi and its various predecessor companies for more than 20 years in Germany, France, and the United States in positions of increasing responsibility, including her role as Vice President, Business Development for Oncology and Immuno-Inflammation for Sanofi-Genzyme. During her tenure at Sanofi, Tanja led numerous transactions, from strategic platform collaborations to early and late-stage licensing deals, as well as several structured company acquisitions.

Tanja earned her law degree and JD at the Karl Ruprecht University in Heidelberg, Germany. She also successfully completed the CEDEP General Management Program at INSEAD in France. In her free time, Tanja enjoys traveling, visiting her family and friends in Germany, and spending time in her second “hometowns” of Paris and Miami.